homocysteine and Hyperlipemia

homocysteine has been researched along with Hyperlipemia in 115 studies

Research

Studies (115)

TimeframeStudies, this research(%)All Research%
pre-19902 (1.74)18.7374
1990's23 (20.00)18.2507
2000's72 (62.61)29.6817
2010's15 (13.04)24.3611
2020's3 (2.61)2.80

Authors

AuthorsStudies
Almer, G; Brunner, MS; Bubalo, V; Cvirn, G; Diwoky, C; Frank, S; Groselj-Strele, A; Herrmann, M; Hoefler, G; Holzapfel, GA; Hörl, G; Kolb, D; Kratky, D; Lechleitner, M; Leitinger, G; Mangge, H; Marsche, G; Niedrist, T; Opriessnig, P; Oswald, W; Paar, M; Rechberger, GN; Schauer, S; Schoiswohl, G; Schwarz, AN; Sommer, G; Tehlivets, O; Wolinski, H1
Cao, P; Chan, L; Chan, P; Chang, Z; Chao, Y; Chen, Z; Deng, B; Lyu, Q; Pan, Y; Que, R; Tan, EK; Wang, Q; Wang, T; Wang, Y; Xu, L; Yang, W; Yenari, MA; Yuan, F; Zhu, S1
Imam, MU; Ishaka, A; Ismail, M1
Chattopadhyay, S; Dash, M; De, SK; Dey, A; Jana, L; Jana, S; Maity, PP; Perveen, H1
Chen, Q; Hsu, YH; Jiang, S; Venners, SA; Wang, X; Xing, H; Xu, X; Zhong, G1
Chu, L; Dong, N; Wang, B; Xiao, L1
Cheng, Y; Hua, X; Jiang, YD; Liang, Y; Ma, CJ; Ma, SC; Tian, J; Wang, J; Yang, AN; Yang, XL1
Chen, Y; Kang, B; Li, Y; Liang, R; Liang, Y; Lv, W; Xie, J; Zhou, Y1
Reimann, M; Weiss, N; Ziemssen, T1
Reimann, M; Rüdiger, H; Weiss, N; Ziemssen, T1
Bonaterra, G; Dugi, KA; Edler, L; Hildebrandt, W; Kinscherf, R; Sauer, R1
La'ulu, SL; Pfeiffer, CM; Rawlins, ML; Roberts, WL; Zhang, M1
Choi, YM; Choue, R; Lim, HJ1
Bansal, V; Kalita, J; Kumar, G; Misra, UK1
Huang, L; Li, Y; Song, XM; Zhu, WL1
Collins, P; Cooney, MT; Daly, C; Fitzgerald, AP; Graham, IM; O'Callaghan, P1
Carru, C; Hare, DL; Jin, X; Lau, E; Learmont, J; Schwartz, GD; Sutarga, K; Wijaya, BP; Wookey, PJ; Zinellu, A; Zulli, A1
Seymen, HO; Seymen, P; Titiz, MI; Türkmen, MF; Yildiz, M1
Chatzopoulos, S; Hatzitolios, A; Mikhailidis, D; Ntaios, G; Savopoulos, C1
Ahn, YK; Baek, SH; Byun, YS; Cho, KI; Choi, DJ; Choi, SW; Choi, YS; Jang, Y; Jeon, DW; Kim, JY; Kim, KS; Kim, YJ; Lee, SH; Min, PK; Rha, SW1
Hayes, KC; Khosla, P1
Bian, H; Chang, XX; Gao, X; Xia, MF; Xu, Q; Yan, HM; Zhu, TF1
Kurban, S; Mehmetoglu, I; Polat, H; Yerlikaya, FH1
Gong, H; Jiang, Y; Shi, Y; Sun, T; Sun, W; Wang, J; Wei, J; Yang, B; Zhang, H1
Bornstein, S; Julius, U; Müller, G; Rodionov, RN; Tselmin, S1
Connelly, PW; Cunnane, SC; Faulkner, D; Jackson, CJ; Jenkins, DJ; Josse, RG; Kendall, CW; Leiter, LA; Parker, T; Vidgen, E1
Acosta, AM; Cisternas, M; Gutiérrez, MA; Jacobelli, S; Klaassen, J1
Connelly, PW; Faulkner, D; Haight, JS; Jenkins, DJ; Kendall, CW; Lapsley, KG; Marchie, A; Parker, TL; Qian, W; Spiller, GA; Vidgen, E1
Elisaf, M1
McLaughlin, MA; Nguyen, VH1
Baumann, G; Stangl, K; Stangl, V1
Bushnell, CD; Goldstein, LB1
Narkiewicz, M; Rutkowski, B; Wasilewska, A; Łysiak-Szydłowska, W1
Stone, NJ1
Biciková, M; Dvoráková, K; Hill, M; Stárka, L; Tallová, J; Vrbíková, J1
Prichard, S1
Boysen, G; Brander, T; Christensen, H; Gideon, R; Truelsen, T1
Griffin, BP; Novaro, GM1
Ceska, R; Grauova, B; Haas, T; Hradec, J; Kozich, V; Krijt, J; Malik, J; Melenovsky, V; Stulc, T; Wichterle, D1
Chasiotis, G; Elisaf, MS; Kakafika, A; Milionis, HJ; Papakostas, J; Seferiadis, K1
Bharadwaj, RP; Dwivedi, RN; Gupta, OK; Narain, VS; Puri, A; Singh, S1
Connelly, PW; Faulkner, D; Jenkins, DJ; Josse, RG; Kendall, CW; Lapsley, KG; Leiter, LA; Marchie, A; Parker, TL; Trautwein, EA; Vidgen, E1
Dierkes, J; Luley, C; Westphal, S1
Choy, PC; Mymin, D; O, K; Siow, YL1
Bottiglieri, T; Caso, V; Conte, C; Corea, F; Floridi, A; Lanari, A; Parnetti, L; Santucci, A1
Al-Waili, NS1
Baró, L; Boza, JJ; Carrero, JJ; Castillo, R; Fonollá, J; González-Santiago, M; Jiménez, J; López-Huertas, E; Martínez-Férez, A1
Aikawa, M; Kobayashi, H; Kobori, Y; Matsuoka, O; Shindo, N; Takazawa, K; Tanaka, N; Teramoto, T; Yamashina, A1
Herer, P; Luboshitzky, R1
Afrasyap, L; Oztürk, G1
Dobordzhginidze, LM1
Bozic, M; Fressart, MM; Keber, I; Sebestjen, M; Simcic, S; Stegnar, M; Zegura, B1
Racek, J; Rusnáková, H; Siala, KK; Trefil, L1
Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR1
Assmann, G; Cullen, P; Schulte, H1
Písaríková, A; Stanková, B; Tvrzická, E; Vecka, M; Zák, A; Zeman, M2
Nubé, MJ; Nurmohamed, SA1
Torre-Villalvazo, I; Torres, N; Tovar, AR1
Erzen, B; Keber, I; Poredos, P; Sabovic, M; Sebestjen, M; Simcic, S; Zegura, B1
Bauer, K; Fischer, P; Huber, K; Jungwirth, S; Tragl, KH; Zehetmayer, S1
Kneteman, N; Lilly, L; Marotta, P; Peltekian, K; Roy, A; Scudamore, C; Tchervenkov, J1
Arai, H1
Bozzini, C; Corrocher, R; Faccini, G; Friso, S; Girelli, D; Guarini, P; Martinelli, N; Olivieri, O; Pizzolo, F; Trabetti, E1
Cattaneo, M; Faioni, EM; Fontana, G; Lombardi, R; Lussana, F; Maioli, C; Moroni, G; Podda, GM; Ponticelli, C1
Archetti, S; Borroni, B; Cesana, BM; Ferrari, M; Padovani, A1
Li, D; Wang, LJ; Wang, Q; Xie, HB; Yu, P; Yu, XM; Zhang, YH; Zhou, XQ2
Barros, N; Cardien, LC; D'Almeida, V; Ferreira, SR; Garofolo, L; Miranda, F1
Arai, H; Egashira, T; Hattori, H; Horibe, H; Ishikawa, Y; Itakura, H; Kita, T; Mabuchi, H; Matsuzawa, Y; Nakaya, N; Oikawa, S; Ouchi, Y; Saito, Y; Sasaki, J; Teramoto, T; Yamada, N; Yamamoto, A1
Glueck, CJ; Lang, JE; Shaw, P; Sieve-Smith, L; Tracy, T; Wang, Y1
Superko, HR1
Penny, WJ1
Le, NA1
Blom, HJ; Kluijtmans, LA; Kok, FJ; Kruyssen, DA; Refsum, H; Ueland, PM; Verhoef, P1
Chook, P; Sanderson, JE; Woo, KS; Young, RP1
Tonstad, S1
Abbate, R; Brunelli, T; Capanni, M; Fatini, C; Gensini, GF; Marcucci, R; Pepe, G; Prisco, D; Sardi, I; Simonetti, I1
Wanner, C; Zimmermann, J1
de Lorgeril, M; Lacan, P; Paillard, F; Richard, G; Salen, P1
Arnesen, H; Brude, IR; Drevon, CA; Finstad, HS; Hjermann, I; Nenseter, MS; Sandstad, B; Seljeflot, I; Solvoll, K1
McNamara, JR; Schaefer, EJ; Seman, LJ1
Aarsland, T; Grundt, H; Hetland, O; Mansoor, MA; Nilsen, DW; Woie, L1
Beilby, JP; Hung, J; McQuillan, BM; Nidorf, M; Thompson, PL1
Titus, K1
Clagett, GP; Jackson, MR; McIntyre, KE; Modrall, JG; Valentine, RJ1
Bruckert, E; Foglietti, MJ; Giral, P; Jacob, N; Turpin, G1
Chait, A; Clark, S; Hatton, DC; Haynes, RB; Holcomb, S; Kris-Etherton, P; McCarron, DA; McMahon, M; Metz, JA; Morris, CD; Oparil, S; Pi-Sunyer, FX; Resnick, LM; Snyder, GW; Stern, JS1
Chan, JC; Chan, N1
Ciuffetti, G; Locati, EH; Lombardini, R; Lupattelli, G; Mannarino, E; Rufini, S; Siepi, D1
Chait, A; Clark, S; Eastgard, RL; Hatton, DC; Haynes, RB; Holcomb, S; Kris-Etherton, P; Malinow, MR; McCarron, DA; McMahon, M; Metz, JA; Morris, CD; Nevin, DN; Oparil, S; Pi-Sunyer, FX; Resnick, LM; Reusser, ME; Snyder, GW; Stern, JS1
Abramowicz, D; Broeders, N; Knoop, C1
Ashley, J; St Jeor, S; Winston, M1
Hughes, S1
Bloomgarden, ZT1
Hamada, C; Kitaoka, M; Kurihara, H; Kuwaki, T; Morita, H; Nagai, R; Suzuki, S; Yazaki, Y1
McCarty, MF1
Garber, AJ1
Al-Ahmad, A; Konstam, MA; Salem, DN; Sarnak, MJ1
Brown, WV1
Abletshauser, C; Goedicke, C; Haak, E; Haak, T; Hermanns, N; Kusterer, K; Lackner, K; Martin, N; Usadel, KH; Weber, S1
Pinn, G1
Doolman, R; Gavendo, S; Harats, D; Marko, D; Sela, BA; Shaish, A; Yodfat, O1
Banditt, P; Dierkes, J; Kunstmann, S; Lössner, A; Luley, C; Westphal, S1
Ceska, R; Grauová, B; Kozich, V; Melenovský, V; Stulc, T1
Gao, W; Jiang, N; Meng, Z; Tang, J1
Frohlich, JJ; Godin, DV; Green, TJ; Hill, J; McManus, BM; Moghadasian, MH; Nadji, M; Nguyen, LB; Scudamore, CH; Shefer, S; Yang, Y1
Bostom, AG1
Hiatt, WR; Regensteiner, JG1
Goodson, N1
Knopp, RH1
Asnani, S; Desouza, C; Fonseca, V; Homan, J; McNamara, DB; Murthy, SN1
McCully, KS1
Mitsumata, M; Nishida, K; Tomikawa, M; Yamane, T; Yoshida, Y1

Reviews

28 review(s) available for homocysteine and Hyperlipemia

ArticleYear
Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: a systematic review and metaanalysis.
    Atherosclerosis, 2011, Volume: 214, Issue:1

    Topics: Administration, Oral; Aged; Antihypertensive Agents; Clinical Trials as Topic; Fibric Acids; Homocysteine; Humans; Hydrochlorothiazide; Hyperhomocysteinemia; Hyperlipidemias; Hypoglycemia; Iatrogenic Disease; Metabolic Syndrome; Metformin; Middle Aged

2011
Effects of fibrates on serum metabolic parameters.
    Current medical research and opinion, 2002, Volume: 18, Issue:5

    Topics: Anticholesteremic Agents; Carbohydrates; Cholesterol, HDL; Clinical Trials as Topic; Coronary Disease; Drug Interactions; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney; Lipoproteins; Liver; Triglycerides; Uric Acid

2002
Coronary artery disease in women: a review of emerging cardiovascular risk factors.
    The Mount Sinai journal of medicine, New York, 2002, Volume: 69, Issue:5

    Topics: Anticholesteremic Agents; Biomarkers; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Oxidative Stress; Risk Factors; Thrombophilia; Women's Health

2002
Coronary atherogenic risk factors in women.
    European heart journal, 2002, Volume: 23, Issue:22

    Topics: Blood Coagulation Factors; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Complications; Exercise; Female; Homocysteine; Humans; Hyperlipidemias; Hypertension; Lipoprotein(a); Menopause; Obesity; Pedigree; Risk Factors; Smoking; Stress, Psychological; Triglycerides

2002
Risk factors for coronary artery disease in patients with renal failure.
    The American journal of the medical sciences, 2003, Volume: 325, Issue:4

    Topics: Calcium; Coronary Artery Disease; Diabetes Mellitus; Homocysteine; Humans; Hyperlipidemias; Hypertension; Inflammation; Nitric Oxide; Oxidants; Phosphates; Renal Dialysis; Renal Insufficiency; Risk Factors; Smoking

2003
Calcific aortic stenosis: another face of atherosclerosis?
    Cleveland Clinic journal of medicine, 2003, Volume: 70, Issue:5

    Topics: Aortic Valve Stenosis; Calcinosis; Disease Progression; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Risk Factors

2003
The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.
    Expert opinion on drug safety, 2004, Volume: 3, Issue:2

    Topics: Fenofibrate; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypolipidemic Agents; Niacin; Risk Factors; Simvastatin

2004
Lipids and atherosclerosis.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 2004, Volume: 82, Issue:1

    Topics: Arteriosclerosis; Chemokines; Cholesterol; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Lipoproteins, LDL; Risk Factors

2004
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
    Kardiologiia, 2004, Volume: 44, Issue:3

    Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides

2004
Reverse epidemiology: paradoxical observations in haemodialysis patients.
    The Netherlands journal of medicine, 2005, Volume: 63, Issue:10

    Topics: Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Glycation End Products, Advanced; Homocysteine; Humans; Hyperlipidemias; Hypertension, Renal; Hypotension; Kidney Failure, Chronic; Risk Factors

2005
Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders.
    The Journal of nutritional biochemistry, 2006, Volume: 17, Issue:6

    Topics: Adipocytes; Bile Acids and Salts; Cholesterol; Cholesterol, LDL; Diabetes Mellitus; Glucagon; Homeostasis; Homocysteine; Humans; Hyperlipidemias; Insulin; Intestinal Absorption; Kidney Diseases; Lipid Metabolism; Liver; Liver Diseases; Obesity; Soybean Proteins; Sterol Regulatory Element Binding Protein 1

2006
[Importance of vascular aspects in Alzheimer's disease].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2006, Volume: 43, Issue:4

    Topics: Accidental Falls; Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cause of Death; Cerebral Infarction; Diabetes Complications; Homocysteine; Humans; Hyperlipidemias; Hypertension; Life Style; Pneumonia, Aspiration; Risk Factors

2006
Lipid disorders contributing to coronary heart disease: an update.
    Current problems in cardiology, 1996, Volume: 21, Issue:11

    Topics: Cholesterol, LDL; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Cost-Benefit Analysis; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Risk

1996
Hyperlipidemia and cardiovascular disease.
    Current opinion in lipidology, 1997, Volume: 8, Issue:2

    Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperlipidemias

1997
New risk factors for coronary heart disease in Asia.
    International journal of cardiology, 1997, Dec-01, Volume: 62 Suppl 1

    Topics: Adult; Aged; Aging; Asia; Child; Cholesterol, HDL; Coronary Disease; Endothelium, Vascular; Homocysteine; Humans; Hyperlipidemias; Insulin Resistance; Middle Aged; Obesity; Risk Factors; Smoking

1997
Causes of coronary heart disease in patients on renal replacement therapy.
    Kidney & blood pressure research, 1998, Volume: 21, Issue:2-4

    Topics: Animals; Apolipoproteins B; Coronary Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipoprotein(a); Renal Dialysis; Risk Factors

1998
Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factors.
    Current opinion in cardiology, 1999, Volume: 14, Issue:2

    Topics: Biomarkers; Coronary Disease; Diet; Female; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein(a); Male; Risk Factors; Triglycerides

1999
A panorama of cardiac risk.
    CAP today, 1999, Volume: 13, Issue:2

    Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E

1999
Diet controversies in lipid therapy.
    The Journal of cardiovascular nursing, 2000, Volume: 14, Issue:2

    Topics: Antioxidants; Diet; Dietary Fats; Homocysteine; Humans; Hyperlipidemias; Nursing Research; Phytotherapy

2000
Novel risk factors for coronary heart disease: emerging connections.
    The Journal of cardiovascular nursing, 2000, Volume: 14, Issue:2

    Topics: Arteriosclerosis; Coronary Disease; Hemostasis; Homocysteine; Humans; Hyperlipidemias; Inflammation; Iron; Lipoproteins; Risk Factors

2000
Attenuating cardiovascular risk factors in patients with type 2 diabetes.
    American family physician, 2000, Dec-15, Volume: 62, Issue:12

    Topics: Anticholesteremic Agents; Antihypertensive Agents; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lipoproteins; Patient Education as Topic; Risk Factors; Smoking Cessation; Teaching Materials

2000
Cause and management of heart failure in patients with chronic renal disease.
    Seminars in nephrology, 2001, Volume: 21, Issue:1

    Topics: Diabetes Complications; Heart Failure; Homocysteine; Humans; Hyperlipidemias; Hypertension; Kidney Failure, Chronic; Renal Dialysis; Risk Factors; Uremia

2001
Risk factors for vascular disease in patients with diabetes.
    Diabetes, obesity & metabolism, 2000, Volume: 2 Suppl 2

    Topics: Diabetic Angiopathies; Homocysteine; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Insulin Resistance; Models, Cardiovascular; Obesity; Risk Factors; Smoking; Thrombophilia

2000
Current medical therapies for patients with peripheral arterial disease: a critical review.
    The American journal of medicine, 2002, Volume: 112, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Cardiovascular Diseases; Cilostazol; Diabetes Mellitus; Estrogens; Exercise; Homocysteine; Humans; Hyperlipidemias; Hypertension; Intermittent Claudication; Meta-Analysis as Topic; Myocardial Ischemia; Pentoxifylline; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Tetrazoles

2002
Coronary artery disease and rheumatoid arthritis.
    Current opinion in rheumatology, 2002, Volume: 14, Issue:2

    Topics: Arthritis, Rheumatoid; C-Reactive Protein; Comorbidity; Coronary Artery Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypertension; Risk Factors; Smoking; Survival Analysis; Survival Rate

2002
Risk factors for coronary artery disease in women.
    The American journal of cardiology, 2002, Jun-20, Volume: 89, Issue:12A

    Topics: C-Reactive Protein; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Metabolic Syndrome; Risk Factors

2002
Hormones and homocysteine.
    Minerva endocrinologica, 2002, Volume: 27, Issue:3

    Topics: Diabetic Angiopathies; Homocysteine; Hormones; Humans; Hyperhomocysteinemia; Hyperlipidemias; Methionine; Vascular Diseases

2002
Homocystine, atherosclerosis and thrombosis: implications for oral contraceptive users.
    The American journal of clinical nutrition, 1975, Volume: 28, Issue:5

    Topics: Amino Acid Metabolism, Inborn Errors; Animals; Arteriosclerosis; Child; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Embolism; Female; Glucose; Homocysteine; Homocystine; Homocystinuria; Humans; Hydro-Lyases; Hyperlipidemias; Methionine; Thrombosis

1975

Trials

28 trial(s) available for homocysteine and Hyperlipemia

ArticleYear
Different responses of the retinal and cutaneous microcirculation to transient dysmetabolic conditions.
    Atherosclerosis. Supplements, 2015, Volume: 18

    Topics: Acetylcholine; Administration, Cutaneous; Adult; Dietary Fats; Germany; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Iontophoresis; Laser-Doppler Flowmetry; Light; Male; Methionine; Microcirculation; Microvessels; Photic Stimulation; Predictive Value of Tests; Regional Blood Flow; Reproducibility of Results; Retinal Vessels; Skin; Vasodilation; Vasodilator Agents; Young Adult

2015
Acute hyperlipidemia but not hyperhomocysteinemia impairs reflex regulation of the cardiovascular system.
    Atherosclerosis. Supplements, 2015, Volume: 18

    Topics: Adrenergic beta-Agonists; Adult; Baroreflex; Blood Pressure; Cardiovascular System; Dietary Fats; Germany; Heart Rate; Hemodynamics; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methionine; Sympathetic Nervous System; Time Factors; Vagus Nerve; Vasodilator Agents; Young Adult

2015
Oral N-acetylcysteine reduces plasma homocysteine concentrations regardless of lipid or smoking status.
    The American journal of clinical nutrition, 2015, Volume: 102, Issue:5

    Topics: Acetylcysteine; Administration, Oral; Adult; Antihypertensive Agents; Antioxidants; Biotransformation; Cholesterol; Cysteine; Double-Blind Method; Glutathione; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Leukocytes, Mononuclear; Male; Middle Aged; Smoking; Triglycerides

2015
Dietary intervention with emphasis on folate intake reduces serum lipids but not plasma homocysteine levels in hyperlipidemic patients.
    Nutrition research (New York, N.Y.), 2008, Volume: 28, Issue:11

    Topics: Adult; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Chi-Square Distribution; Diet; Diet Records; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Korea; Lipids; Male; Middle Aged; Vitamins

2008
Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.
    Atherosclerosis, 2012, Volume: 221, Issue:1

    Topics: Aged; Asian People; Biomarkers; Blood Glucose; Blood Urea Nitrogen; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Creatinine; Drug Combinations; Enzymes; Female; Fenofibrate; Fluorobenzenes; Hemoglobins; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipids; Liver; Male; Middle Aged; Muscle, Skeletal; Patient Selection; Pyrimidines; Republic of Korea; Rhabdomyolysis; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome

2012
Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women.
    The American journal of clinical nutrition, 2002, Volume: 76, Issue:2

    Topics: Blood Pressure; Cholesterol; Coronary Disease; Cross-Over Studies; Dietary Proteins; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Hyperlipidemias; Isoflavones; Lipids; Male; Middle Aged; Postmenopause; Soybean Proteins

2002
Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial.
    Circulation, 2002, Sep-10, Volume: 106, Issue:11

    Topics: Aged; Coronary Disease; Cross-Over Studies; Dietary Supplements; Eating; Female; Homocysteine; Humans; Hyperlipidemias; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lung; Male; Middle Aged; Nitric Oxide; Nuts; Prunus; Risk Factors

2002
Homocysteine testing in patients with acute ischemic stroke.
    Neurology, 2002, Nov-26, Volume: 59, Issue:10

    Topics: Acute Disease; Age Factors; Aged; Analysis of Variance; Biomarkers; Diabetes Mellitus; Embolism; Female; Homocysteine; Humans; Hyperlipidemias; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors; Stroke

2002
Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
    American heart journal, 2003, Volume: 146, Issue:1

    Topics: Cholesterol; Creatinine; Cysteine; Female; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Prospective Studies; Statistics as Topic; Triglycerides; Uric Acid

2003
Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
    Journal of clinical pharmacology, 2003, Volume: 43, Issue:8

    Topics: Analysis of Variance; Atorvastatin; Blood Glucose; Female; Fenofibrate; Heptanoic Acids; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Simvastatin; Uric Acid

2003
The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia.
    Metabolism: clinical and experimental, 2003, Volume: 52, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Cholesterol; Cholesterol, Dietary; Dietary Carbohydrates; Dietary Fats; Dietary Fiber; Erythrocyte Deformability; Female; Food Preferences; Homocysteine; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Phytosterols; Prunus; Risk Factors; Satiety Response; Soybean Proteins

2003
Natural honey lowers plasma glucose, C-reactive protein, homocysteine, and blood lipids in healthy, diabetic, and hyperlipidemic subjects: comparison with dextrose and sucrose.
    Journal of medicinal food, 2004,Spring, Volume: 7, Issue:1

    Topics: Adult; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glucose; Homocysteine; Honey; Humans; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Lipids; Male; Middle Aged; Sucrose

2004
Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia.
    Nutrition (Burbank, Los Angeles County, Calif.), 2004, Volume: 20, Issue:6

    Topics: Aged; Animals; Antioxidants; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperlipidemias; Lipids; Male; Malondialdehyde; Middle Aged; Milk; Oleic Acid; Risk Factors; Spain; Time Factors; Vascular Cell Adhesion Molecule-1; Vitamin B 6; Vitamin B Complex; Vitamin E

2004
Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism.
    Neuro endocrinology letters, 2004, Volume: 25, Issue:4

    Topics: Adult; Biomarkers; Blood Pressure; C-Reactive Protein; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Hypothyroidism; Middle Aged; Reference Values; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Sterols; Triglycerides

2004
Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors.
    Thrombosis and haemostasis, 2004, Volume: 92, Issue:5

    Topics: Adult; Arteriosclerosis; Blood Coagulation; Blood Coagulation Factors; Body Weight; C-Reactive Protein; Cholesterol, LDL; Clofibric Acid; Cytokines; Fenofibrate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pyridines; Risk Factors

2004
The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia.
    Physiological research, 2005, Volume: 54, Issue:1

    Topics: Adult; Aged; Antioxidants; Biomarkers; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress

2005
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:3

    Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome

2005
N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
    The Journal of nutritional biochemistry, 2006, Volume: 17, Issue:6

    Topics: Adult; Albuminuria; Cholesterol Esters; Clofibric Acid; Diabetes Mellitus, Type 1; Dietary Supplements; Fatty Acids; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; Phosphatidylcholines; Placebos; Stearic Acids; Triglycerides

2006
[Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
    Casopis lekaru ceskych, 2005, Volume: 144, Issue:11

    Topics: Adult; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fenofibrate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Inflammation Mediators; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Single-Blind Method

2005
Lipid-lowering drugs and homocysteine.
    Lancet (London, England), 1999, Jan-16, Volume: 353, Issue:9148

    Topics: Amino Acids; Coronary Disease; Double-Blind Method; Fenofibrate; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Simvastatin

1999
Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers.
    European journal of clinical investigation, 1999, Volume: 29, Issue:2

    Topics: Adult; Biomarkers; Cardiovascular Diseases; Diet; Double-Blind Method; Fatty Acids, Omega-3; Glutathione Peroxidase; Homocysteine; Humans; Hyperlipidemias; Leukocytes, Mononuclear; Male; Middle Aged; Risk Factors; RNA, Messenger; Smoking; Vitamins

1999
Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia.
    Thrombosis and haemostasis, 1999, Volume: 81, Issue:4

    Topics: Adolescent; Adult; Aged; Arteriosclerosis; Bleeding Time; Body Mass Index; Double-Blind Method; Fatty Acids; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Middle Aged; Patient Compliance; Phospholipids; Plasminogen Activator Inhibitor 1; Platelet Count; Risk Factors; Thrombosis; Triglycerides

1999
Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trial.
    Journal of the American Dietetic Association, 1999, Volume: 99, Issue:9

    Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diet; Female; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Insulin; Male; Middle Aged; Nutritive Value; Patient Compliance; Risk Factors; Treatment Outcome; Weight Loss

1999
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease.
    The American journal of clinical nutrition, 1999, Volume: 70, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Pyridoxine; Risk Factors; Vitamin B 12

1999
Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia.
    Atherosclerosis, 2001, Volume: 155, Issue:2

    Topics: Anticholesteremic Agents; Arteriosclerosis; Blood Proteins; Capillaries; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Fatty Acids, Monounsaturated; Fluvastatin; Hemostasis; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperemia; Hyperlipidemias; Indoles; Laser-Doppler Flowmetry; Microcirculation; Microscopy, Video; Risk Factors; Time Factors; Triglycerides

2001
Homocysteine elevation with fibrates: is it a class effect?
    The Israel Medical Association journal : IMAJ, 2001, Volume: 3, Issue:4

    Topics: Adult; Bezafibrate; Clofibric Acid; Dietary Fats; Female; Fibric Acids; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides

2001
Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate.
    Atherosclerosis, 2001, Volume: 158, Issue:1

    Topics: Cross-Over Studies; Double-Blind Method; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pyridoxine; Vitamin B 12; Vitamins

2001
Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy.
    Nutrition (Burbank, Los Angeles County, Calif.), 2001, Volume: 17, Issue:9

    Topics: Arteriosclerosis; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Pilot Projects; Risk Factors

2001

Other Studies

59 other study(ies) available for homocysteine and Hyperlipemia

ArticleYear
Deficiency of B vitamins leads to cholesterol-independent atherogenic transformation of the aorta.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 154

    Topics: Animals; Aorta; Atherosclerosis; Cholesterol; Diet, Atherogenic; Homocysteine; Humans; Hypercholesterolemia; Hyperlipidemias; Rabbits; Vitamin B Complex

2022
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
    Aging, 2020, 08-15, Volume: 12, Issue:15

    Topics: Age Factors; Aged; Biomarkers; Blood Glucose; China; Cholesterol, LDL; Dementia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Inflammation; Male; Middle Aged; Parkinson Disease; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Vascular Diseases

2020
Nanoemulsification of Rice Bran Wax Policosanol Enhances Its Cardio-protective Effects via Modulation of Hepatic Peroxisome Proliferator-activated Receptor gamma in Hyperlipidemic Rats.
    Journal of oleo science, 2020, Volume: 69, Issue:10

    Topics: Animals; Cardiotonic Agents; Diet, High-Fat; Fatty Alcohols; Gene Expression; Homocysteine; Hyperlipidemias; Liver; Male; Myocardium; Oryza; Phytotherapy; PPAR gamma; Rats, Sprague-Dawley; RNA, Messenger; Waxes

2020
Attenuation of utero-toxicity, metabolic dysfunction and inflammation by soy protein concentrate in rats exposed to fluoridated water: consequence of hyperlipidemia in parallel with hypohomocysteinemia.
    Environmental science and pollution research international, 2018, Volume: 25, Issue:36

    Topics: Animals; Antioxidants; Body Weight; Estrogen Receptor alpha; Female; Homocysteine; Humans; Hyperlipidemias; Inflammation; Lipid Peroxidation; Ovary; Rats, Wistar; Sodium Fluoride; Soybean Proteins; Uterus

2018
Effect of simvastatin on plasma homocysteine levels and its modification by MTHFR C677T polymorphism in Chinese patients with primary hyperlipidemia.
    Cardiovascular therapeutics, 2013, Volume: 31, Issue:4

    Topics: Administration, Oral; Adult; Asian People; Biomarkers; Chi-Square Distribution; China; Chromatography, High Pressure Liquid; Down-Regulation; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Polymorphism, Genetic; Simvastatin; Time Factors; Treatment Outcome

2013
Plasma homocysteine concentrations in the acute phase after central retinal vein occlusion in a Chinese population.
    Current eye research, 2013, Volume: 38, Issue:11

    Topics: Acute Disease; Aged; Asian People; Cardiovascular Diseases; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Retinal Vein Occlusion; Risk Factors; Vitamin B 12

2013
Homocysteine induces blood vessel global hypomethylation mediated by LOX-1.
    Genetics and molecular research : GMR, 2014, May-16, Volume: 13, Issue:2

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Blood Vessels; DNA Methylation; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Mice; Scavenger Receptors, Class E

2014
[Association of C677T gene polymorphisms of methylenetetrahydrofolate reductase and plasma homocysteine level with hyperlipidemia].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2014, Volume: 34, Issue:8

    Topics: Adult; Gene Frequency; Genotype; Homocysteine; Humans; Hyperlipidemias; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length

2014
Performance characteristics of six homocysteine assays.
    American journal of clinical pathology, 2008, Volume: 130, Issue:6

    Topics: Autoanalysis; Chromatography, High Pressure Liquid; Clinical Chemistry Tests; Female; Hemolysis; Homocysteine; Humans; Hyperlipidemias; Immunoassay; Jaundice; Male; Reproducibility of Results; Uncertainty

2008
Relationship of homocysteine with other risk factors and outcome of ischemic stroke.
    Clinical neurology and neurosurgery, 2009, Volume: 111, Issue:4

    Topics: Adult; Aged; Brain Ischemia; Comorbidity; Diabetes Mellitus; Diet, Vegetarian; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; India; Male; Middle Aged; Obesity; Risk Factors; Severity of Illness Index; Smoking; Stroke; Tomography, X-Ray Computed; Vitamin B 12

2009
Plasma homocysteine and gene polymorphisms associated with the risk of hyperlipidemia in northern Chinese subjects.
    Biomedical and environmental sciences : BES, 2008, Volume: 21, Issue:6

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Asian People; Base Sequence; Case-Control Studies; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors

2008
Homocysteine increases the risk associated with hyperlipidaemia.
    European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2009, Volume: 16, Issue:2

    Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Europe; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Logistic Models; Male; Middle Aged; Odds Ratio; Pilot Projects; Risk Assessment; Risk Factors; Triglycerides; Up-Regulation

2009
High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:6

    Topics: Analysis of Variance; Animals; Apoptosis; CCAAT-Binding Factor; Coronary Artery Disease; Diet, Atherogenic; Dietary Supplements; Disease Models, Animal; Endothelium, Vascular; Homocysteine; Hyperlipidemias; Male; Methionine; Nitric Oxide; Oxidative Stress; Probability; Rabbits; Random Allocation; Reference Values; Sensitivity and Specificity; Taurine

2009
Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
    Transplantation proceedings, 2009, Volume: 41, Issue:10

    Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cyclosporine; Female; Homocysteine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoprotein(a); Lipoproteins, HDL; Male; Patient Selection; Postoperative Complications; Tacrolimus; Treatment Outcome; Triglycerides; Young Adult

2009
Saturated fat and lipemia: importance of study design and triglyceride structure.
    The American journal of clinical nutrition, 2012, Volume: 96, Issue:1

    Topics: Cholesterol; Diet; Dietary Fats; Fatty Acids; Fatty Acids, Unsaturated; Female; Homocysteine; Humans; Hyperlipidemias; Inflammation Mediators; Lipid Metabolism; Male; Oleic Acid; Palmitic Acid; Plant Oils; Triglycerides

2012
The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet.
    Lipids in health and disease, 2012, Jul-04, Volume: 11

    Topics: Animals; Aorta; Apolipoproteins; Atherosclerosis; Berberine; Cholesterol; Cholesterol, LDL; Diet, High-Fat; Drug Evaluation, Preclinical; Homocysteine; Hydroxymethylglutaryl CoA Reductases; Hyperhomocysteinemia; Hyperlipidemias; Hypolipidemic Agents; Lipids; Liver; Male; Rats; Rats, Sprague-Dawley; Receptors, Lipoprotein; Risk Factors

2012
Plasma ω-3 fatty acid levels negatively and ω-6 fatty acid levels positively associated with other cardiovascular risk factors including homocysteine in severe obese subjects.
    Asia Pacific journal of clinical nutrition, 2012, Volume: 21, Issue:4

    Topics: Adult; Algorithms; Body Mass Index; Cardiovascular Diseases; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Middle Aged; Obesity; Risk Factors; Severity of Illness Index; Turkey; Vitamin B 12 Deficiency; Young Adult

2012
The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice.
    Acta biochimica et biophysica Sinica, 2012, Volume: 44, Issue:10

    Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cholesterol; Cholesterol, Dietary; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Gene Expression; Homocysteine; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Male; Methionine; Mice; Mice, Knockout; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; S-Adenosylhomocysteine; S-Adenosylmethionine; Triglycerides

2012
Homocysteine in lipoprotein apheresis patients--retrospective data analysis in apheresis center of a university hospital.
    Atherosclerosis. Supplements, 2013, Volume: 14, Issue:1

    Topics: Aged; Analysis of Variance; Biomarkers; Blood Component Removal; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Female; Germany; Homocysteine; Hospitals, University; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Treatment Outcome; Triglycerides; Vitamin B Complex

2013
Cardiovascular risk factors in Chilean patients with rheumatoid arthritis.
    The Journal of rheumatology, 2002, Volume: 29, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Chile; Cohort Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Risk Factors

2002
Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis?
    Medical science monitor : international medical journal of experimental and clinical research, 2003, Volume: 9, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Cardiac Surgical Procedures; Case-Control Studies; Cholesterol; Female; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Risk Factors; Triglycerides; Vitamin B 12; Vitamin B 6; Vitamin B Complex

2003
Hyperlipidemia and cardiovascular disease.
    Current opinion in lipidology, 2003, Volume: 14, Issue:2

    Topics: Cardiovascular Diseases; Cholesterol; Environment; Homocysteine; Humans; Hyperlipidemias; Male

2003
Plasma thiols and androgen levels in polycystic ovary syndrome.
    Clinical chemistry and laboratory medicine, 2003, Volume: 41, Issue:2

    Topics: Adolescent; Adult; Age Factors; Androgens; Androstenedione; Case-Control Studies; Cholesterol; Cholesterol, HDL; Dehydroepiandrosterone Sulfate; Estradiol; Female; Glutathione; Homocysteine; Humans; Hyperlipidemias; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Regression Analysis; Sex Hormone-Binding Globulin; Sulfhydryl Compounds; Testosterone

2003
Homocysteine and risk of recurrent stroke.
    Stroke, 2003, Volume: 34, Issue:5

    Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Denmark; Diabetes Mellitus; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Prospective Studies; Recurrence; Risk; Risk Factors; Smoking; Stroke

2003
Homocysteine and lipid levels in young patients with coronary artery disease.
    The Journal of the Association of Physicians of India, 2003, Volume: 51

    Topics: Adult; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperlipidemias; India; Lipids; Male; Risk Factors

2003
Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2004, Volume: 25, Issue:1

    Topics: Aged; Chromatography, High Pressure Liquid; Diabetes Complications; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Male; Risk Factors; Smoking; Stroke

2004
[Influence of serum homocysteine level on coronary atherosclerosis in Japanese].
    Journal of cardiology, 2004, Volume: 43, Issue:5

    Topics: Aged; Coronary Artery Disease; Diabetes Mellitus; Female; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Multivariate Analysis; Radiography; Risk Factors; Severity of Illness Index; Smoking

2004
Ratios of homocysteine and nitrite to high-density lipoprotein in coronary artery patients with the different degree of stenosis.
    Vascular pharmacology, 2004, Volume: 41, Issue:3

    Topics: Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Constriction, Pathologic; Coronary Artery Disease; Evaluation Studies as Topic; Homocysteine; Humans; Hypercholesterolemia; Hyperlipidemias; Middle Aged; Nitrites; Statistics as Topic; Turkey

2004
[Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment].
    Deutsche medizinische Wochenschrift (1946), 2005, Sep-30, Volume: 130, Issue:39

    Topics: Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Genetic Predisposition to Disease; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Assessment

2005
Role of endothelial function and inflammation in patients with cardiovascular risk factors, with and without a history of myocardial infarction.
    Cardiology, 2007, Volume: 107, Issue:1

    Topics: Adult; Analysis of Variance; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Cholesterol; Endothelium, Vascular; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Male; Middle Aged; Myocardial Infarction; Risk Factors; Statistics, Nonparametric; Ultrasonography

2007
Relation between vascular risk factors and cognition at age 75.
    Acta neurologica Scandinavica, 2006, Volume: 114, Issue:2

    Topics: Aged; Aging; Alzheimer Disease; Austria; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cognition Disorders; Cohort Studies; Comorbidity; Cross-Sectional Studies; Female; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Lipoproteins; Male; Neuropsychological Tests; Risk Factors; Smoking; Statistics as Topic; Triglycerides

2006
Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant.
    Transplantation, 2006, Aug-27, Volume: 82, Issue:4

    Topics: Adult; Aged; Female; Graft Rejection; Homocysteine; Humans; Hyperlipidemias; Immunosuppressive Agents; Lipids; Liver Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tacrolimus; Transplantation, Homologous

2006
Homocysteine, traditional risk factors and impaired renal function in coronary artery disease.
    European journal of clinical investigation, 2006, Volume: 36, Issue:10

    Topics: Aged; Coronary Artery Disease; Diabetes Mellitus; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Polymorphism, Genetic; Risk Factors; Vitamin B Complex

2006
Abnormalities of homocysteine and B vitamins in the nephrotic syndrome.
    Thrombosis research, 2007, Volume: 120, Issue:5

    Topics: Adult; Antibodies, Antiphospholipid; Antithrombins; Factor V; Female; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Nephrotic Syndrome; Risk; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamin B Complex

2007
Relationship of vascular risk to the progression of Alzheimer disease.
    Neurology, 2007, Mar-27, Volume: 68, Issue:13

    Topics: Alzheimer Disease; Apolipoproteins E; Cerebral Arteries; Cerebrovascular Disorders; Cholesterol; Disease Progression; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperlipidemias; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors

2007
[Relations of platelet phospholipid fatty acids to thrombotic risk factors in middle-aged and geriatric patients with hyperlipidemia].
    Zhonghua yi xue za zhi, 2007, Jan-09, Volume: 87, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arachidonic Acid; Blood Platelets; Cholesterol; Dietary Fats; Fatty Acids; Female; Homocysteine; Humans; Hyperlipidemias; Linear Models; Male; Middle Aged; Multivariate Analysis; Phospholipids; Risk Factors; Surveys and Questionnaires; Thrombosis; Thromboxane B2

2007
Platelet phospholipid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patients.
    Prostaglandins, leukotrienes, and essential fatty acids, 2007, Volume: 76, Issue:5

    Topics: Aged; Blood Platelets; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Hyperlipidemias; Male; Middle Aged; Phospholipids; Statistics as Topic

2007
Association of increased levels of homocysteine and peripheral arterial disease in a Japanese-Brazilian population.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2007, Volume: 34, Issue:1

    Topics: Age Distribution; Aged; Asian People; Biomarkers; Body Mass Index; Brazil; Cholesterol; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Complications; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Japan; Male; Middle Aged; Obesity; Peripheral Vascular Diseases; Population Surveillance; Prevalence; Retrospective Studies; Risk Factors; Sex Distribution; Triglycerides

2007
Polymorphisms of apolipoprotein e and methylenetetrahydrofolate reductase in the Japanese population.
    Journal of atherosclerosis and thrombosis, 2007, Volume: 14, Issue:4

    Topics: Apolipoproteins E; Asian People; Data Collection; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Japan; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Sex Distribution

2007
Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients.
    The American journal of cardiology, 1995, Jan-15, Volume: 75, Issue:2

    Topics: Aged; Analysis of Variance; Arteriosclerosis; Coronary Disease; Cystathionine; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Methylmalonic Acid; Middle Aged; Pyridoxine; Risk Factors

1995
Hyperlipidaemia and cardiovascular disease.
    Current opinion in lipidology, 1996, Volume: 7, Issue:5

    Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Hyperlipidemias

1996
The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
    Atherosclerosis, 1997, Jul-11, Volume: 132, Issue:1

    Topics: Adult; Aged; Alcohol Drinking; Case-Control Studies; Comorbidity; Coronary Artery Disease; Disease Susceptibility; Erythrocytes; Fasting; Female; Folic Acid; Genes; Genotype; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; Smoking

1997
Correlates of plasma total homocysteine in patients with hyperlipidaemia.
    European journal of clinical investigation, 1997, Volume: 27, Issue:12

    Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Regression Analysis; Sex Factors; Vitamin B 12

1997
The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD).
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Comorbidity; Coronary Disease; Diabetes Mellitus; Disease Susceptibility; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Homocysteine; Hot Temperature; Humans; Hyperlipidemias; Hypertension; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymerase Chain Reaction; Prevalence; Protein Denaturation; Recurrence; Risk Factors; Smoking

1998
Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)
    Circulation, 1999, May-11, Volume: 99, Issue:18

    Topics: Adult; Aged; Amino Acid Substitution; Arteriosclerosis; Carotid Arteries; Carotid Stenosis; Comorbidity; Diet; Female; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Health Surveys; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Obesity; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Pyridoxine; Risk Factors; Smoking; Tunica Intima; Ultrasonography; Vitamin B 12; Western Australia

1999
The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service.
    Journal of vascular surgery, 1999, Volume: 30, Issue:3

    Topics: Adult; Age Factors; Age of Onset; Amputation, Surgical; Arterial Occlusive Diseases; Blood Coagulation Disorders; Blood Pressure; Confidence Intervals; Diabetes Complications; Disease Progression; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Hypertension; Incidence; Ischemia; Lipoprotein(a); Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Peripheral Vascular Diseases; Postoperative Complications; Prevalence; Prospective Studies; Reoperation; Smoking; Treatment Outcome

1999
Cysteine is a cardiovascular risk factor in hyperlipidemic patients.
    Atherosclerosis, 1999, Volume: 146, Issue:1

    Topics: Adult; Age Distribution; Aged; Arteriosclerosis; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Comorbidity; Confidence Intervals; Confounding Factors, Epidemiologic; Cysteine; Female; Homocysteine; Humans; Hyperlipidemias; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Assessment; Risk Factors; Sex Distribution

1999
Implication of fibrate therapy for homocysteine.
    Lancet (London, England), 1999, Oct-02, Volume: 354, Issue:9185

    Topics: Diabetes Mellitus, Type 2; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents

1999
Hyperhomocyst(e)inemia is associated with carotid atherosclerosis.
    Angiology, 1999, Volume: 50, Issue:10

    Topics: Age Factors; Body Mass Index; Carotid Artery Diseases; Carotid Artery, Common; Carotid Artery, Internal; Chromatography, High Pressure Liquid; Creatinine; Diabetes Complications; Female; Fluorescence; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Logistic Models; Male; Middle Aged; Regression Analysis; Risk Factors; Sex Factors; Smoking; Tunica Intima; Tunica Media; Ultrasonography; Vitamin B 12

1999
Drug treatment of lipid disorders.
    The New England journal of medicine, 1999, Dec-23, Volume: 341, Issue:26

    Topics: Clofibric Acid; Creatinine; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Urea

1999
American Diabetes Association annual meeting, 1999: dyslipidemia, endothelial dysfunction, and glycosylation.
    Diabetes care, 2000, Volume: 23, Issue:5

    Topics: Diabetes Mellitus; Endothelium, Vascular; Fatty Acids; Glycated Hemoglobin; Glycation End Products, Advanced; Glycosylation; Homocysteine; Humans; Hyperlipidemias; Lipids; Organizations; United States

2000
Homocysteine as a risk factor for restenosis after coronary angioplasty.
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; Comorbidity; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Male; Middle Aged; Obesity; Recurrence; Risk Factors; Sensitivity and Specificity; Smoking

2000
Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapy.
    Medical hypotheses, 2000, Volume: 55, Issue:3

    Topics: Animals; Betaine; Homocysteine; Hyperlipidemias; Liver; Niacin; Rats; S-Adenosylmethionine

2000
Herbs and metabolic/endocrine disease. From past to present.
    Australian family physician, 2001, Volume: 30, Issue:2

    Topics: Diabetes Mellitus; Gout; Homocysteine; Humans; Hyperlipidemias; Metabolic Diseases; Phytotherapy; Plants, Medicinal

2001
Hyperhomocysteinemia and hyperlipidemia in coronary heart disease.
    Chinese medical journal, 1999, Volume: 112, Issue:7

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases; Point Mutation; Risk Factors; Vitamin B 12

1999
Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:14

    Topics: Animals; Antioxidants; Apolipoproteins E; Blood Glucose; Body Weight; Brain; Cholesterol; Esterification; Genotype; Glial Fibrillary Acidic Protein; Homocysteine; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipidemias; Immunohistochemistry; Kidney; Lipase; Lipids; Lipoproteins, HDL; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurofilament Proteins; Receptors, LDL; Survival Analysis; Time Factors; Tissue Distribution

2001
Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Lancet (London, England), 2001, Nov-24, Volume: 358, Issue:9295

    Topics: Creatinine; Fenofibrate; Gemfibrozil; Glomerular Filtration Rate; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Reproducibility of Results

2001
Bibliography. Current world literature. Nutrition and metabolism.
    Current opinion in lipidology, 2002, Volume: 13, Issue:1

    Topics: Alcohols; Animals; Apolipoproteins E; Arteriosclerosis; Biomarkers; Carbohydrate Metabolism; Cardiovascular Diseases; Dietary Fats, Unsaturated; Fatty Acids, Omega-3; Feeding Behavior; Fish Oils; Flavonoids; Garlic; Genes; Glycine max; Health Education; Homocysteine; Humans; Hyperlipidemias; Insulin Resistance; Leptin; Life Style; Lipid Metabolism; Nutritional Physiological Phenomena; Obesity; Phenols; Polymers; Polyphenols; Probiotics

2002
Morphology and increased growth rate of atherosclerotic intimal smooth-muscle cells.
    Archives of pathology & laboratory medicine, 1988, Volume: 112, Issue:10

    Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Bucladesine; Cell Division; Cells, Cultured; Collagen; Cyclic AMP; Cytological Techniques; DNA; Homocysteine; Hyperlipidemias; Microscopy, Electron; Microscopy, Phase-Contrast; Muscle, Smooth, Vascular; Rabbits

1988